Kiss E - Search Results

1

Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.

Soltész P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G. Soltész P, et al. Among authors: kiss e. Lupus. 2003;12(4):302-7. doi: 10.1191/0961203303lu339oa. Lupus. 2003. PMID: 12729054

2

Cardiac manifestations in antiphospholipid syndrome.

Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Soltész P, et al. Among authors: kiss e. Autoimmun Rev. 2007 Jun;6(6):379-86. doi: 10.1016/j.autrev.2007.01.003. Epub 2007 Jan 31. Autoimmun Rev. 2007. PMID: 17537384 Review.

3

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E. Tarr T, et al. Among authors: kiss e. Clin Rev Allergy Immunol. 2007 Apr;32(2):131-7. doi: 10.1007/s12016-007-0009-8. Clin Rev Allergy Immunol. 2007. PMID: 17916982

4

Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

Lakos G, Kiss E, Regëczy N, Tarján P, Soltész P, Zeher M, Bodolay E, Szakony S, Sipka S, Szegedi G. Lakos G, et al. Among authors: kiss e. Clin Exp Immunol. 1999 Sep;117(3):574-9. doi: 10.1046/j.1365-2249.1999.01007.x. Clin Exp Immunol. 1999. PMID: 10469065 Free PMC article.

5

[Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].

Soltész P, Veres K, Kiss E, Lakos G, Sonkoly I, Muszbek L, Szegedi G. Soltész P, et al. Among authors: kiss e. Orv Hetil. 2000 Dec 24;141(52):2821-5. Orv Hetil. 2000. PMID: 11202118 Hungarian.

6

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.

Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Tarr T, et al. Among authors: kiss e. Lupus. 2007;16(1):39-45. doi: 10.1177/0961203306074767. Lupus. 2007. PMID: 17283584

7

Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.

Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Tarr T, et al. Among authors: kiss e. Lupus. 2007;16(5):324-8. doi: 10.1177/0961203307077993. Lupus. 2007. PMID: 17576733

8

Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.

Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Barath S, et al. Among authors: kiss e. Lupus. 2007;16(7):489-96. doi: 10.1177/0961203307080226. Lupus. 2007. PMID: 17670847

9

Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.

Veres K, Szodoray P, Szekanecz Z, Lakos G, Kiss E, Laczik R, Sipka S, Bodolay E, Zeher M, Muszbek L, Szegedi G, Soltész P. Veres K, et al. Among authors: kiss e. Lupus. 2010 Nov;19(13):1520-6. doi: 10.1177/0961203310374336. Epub 2010 Aug 4. Lupus. 2010. PMID: 20685773

10

Pregnancy in women with systemic lupus erythematosus.

Kiss E, Bhattoa HP, Bettembuk P, Balogh A, Szegedi G. Kiss E, et al. Eur J Obstet Gynecol Reprod Biol. 2002 Mar 10;101(2):129-34. doi: 10.1016/s0301-2115(01)00525-5. Eur J Obstet Gynecol Reprod Biol. 2002. PMID: 11858886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters